Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants

医学 阿哌沙班 拜瑞妥 达比加群 内科学 倾向得分匹配 肾功能 比例危险模型 冲程(发动机) 回顾性队列研究 心房颤动 危险系数 人口 低风险 华法林 置信区间 机械工程 环境卫生 工程类
作者
Justin Ashley,Eric McArthur,Sarah E. Bota,Ziv Harel,Marisa Battistella,Amber O. Molnar,Min Jun,Sunil V. Badve,Amit X. Garg,Douglas G. Manuel,Peter Tanuseputro,Philip S. Wells,Thomas A. Mavrakanas,Emily Rhodes,Manish M. Sood
出处
期刊:American Journal of Kidney Diseases [Elsevier]
卷期号:76 (3): 311-320 被引量:21
标识
DOI:10.1053/j.ajkd.2020.02.446
摘要

Rationale & Objective Evidence for the efficacy of direct oral anticoagulants (DOACs) to prevent cardiovascular (CV) events and mortality in older individuals with a low estimated glomerular filtration rate (eGFR) is lacking. We sought to characterize the association of oral anticoagulant use with CV morbidity in elderly patients with or without reductions in eGFRs, comparing DOACs with vitamin K antagonists (VKAs). Study Design Population-based retrospective cohort study. Settings & Participants All individuals 66 years or older with an initial prescription for oral anticoagulants dispensed in Ontario, Canada, from 2009 to 2016. Exposure DOACs (apixaban, dabigatran, and rivaroxaban) compared with VKAs by eGFR group (≥60, 30-59, and <30 mL/min/1.73 m2). Outcomes The primary outcome was a composite of a CV event (myocardial infarction, revascularization, or ischemic stroke) or mortality. Secondary outcomes were CV events alone, mortality, and hemorrhage requiring hospitalization. Analytical Approach High-dimensional propensity score matching of DOAC to VKA users and Cox proportional hazards regression. Results 27,552 new DOAC users were matched to 27,552 new VKA users (median age, 78 years; 49% women). There was significantly lower risk for CV events or mortality among DOAC users compared with VKA users (event rates of 79.78 vs 99.77 per 1,000 person-years, respectively; HR, 0.82 [95% CI, 0.75-0.90]) and lower risk for hemorrhage (event rates of 10.35 vs 16.77 per 1,000 person-years, respectively; HR, 0.73 [95% CI, 0.58-0.91]). There was an interaction between eGFR and the association of anticoagulant class with the primary composite outcome (P < 0.02): HRs of 1.01 [95% CI, 0.92-1.12], 0.83 [95% CI, 0.75-0.93], and 0.75 [95% CI, 0.51-1.10] for eGFRs of ≥60, 30 to 59, and <30 mL/min/1.73 m2. No interaction was detected for the outcome of hemorrhage. Limitations Retrospective observational study design limits causal inference; dosages of DOACs and international normalized ratio values were not available; low event rates in some subgroups limited statistical power. Conclusions DOACs compared with VKAs were associated with lower risk for the composite of CV events or mortality, an association for which the strength was most apparent among those with reduced eGFRs. The therapeutic implications of these findings await further study. Evidence for the efficacy of direct oral anticoagulants (DOACs) to prevent cardiovascular (CV) events and mortality in older individuals with a low estimated glomerular filtration rate (eGFR) is lacking. We sought to characterize the association of oral anticoagulant use with CV morbidity in elderly patients with or without reductions in eGFRs, comparing DOACs with vitamin K antagonists (VKAs). Population-based retrospective cohort study. All individuals 66 years or older with an initial prescription for oral anticoagulants dispensed in Ontario, Canada, from 2009 to 2016. DOACs (apixaban, dabigatran, and rivaroxaban) compared with VKAs by eGFR group (≥60, 30-59, and <30 mL/min/1.73 m2). The primary outcome was a composite of a CV event (myocardial infarction, revascularization, or ischemic stroke) or mortality. Secondary outcomes were CV events alone, mortality, and hemorrhage requiring hospitalization. High-dimensional propensity score matching of DOAC to VKA users and Cox proportional hazards regression. 27,552 new DOAC users were matched to 27,552 new VKA users (median age, 78 years; 49% women). There was significantly lower risk for CV events or mortality among DOAC users compared with VKA users (event rates of 79.78 vs 99.77 per 1,000 person-years, respectively; HR, 0.82 [95% CI, 0.75-0.90]) and lower risk for hemorrhage (event rates of 10.35 vs 16.77 per 1,000 person-years, respectively; HR, 0.73 [95% CI, 0.58-0.91]). There was an interaction between eGFR and the association of anticoagulant class with the primary composite outcome (P < 0.02): HRs of 1.01 [95% CI, 0.92-1.12], 0.83 [95% CI, 0.75-0.93], and 0.75 [95% CI, 0.51-1.10] for eGFRs of ≥60, 30 to 59, and <30 mL/min/1.73 m2. No interaction was detected for the outcome of hemorrhage. Retrospective observational study design limits causal inference; dosages of DOACs and international normalized ratio values were not available; low event rates in some subgroups limited statistical power. DOACs compared with VKAs were associated with lower risk for the composite of CV events or mortality, an association for which the strength was most apparent among those with reduced eGFRs. The therapeutic implications of these findings await further study.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热心市民小红花应助杜青采纳,获得10
刚刚
爆米花应助小学生1005采纳,获得80
刚刚
斯文败类应助xj采纳,获得10
刚刚
婷婷发布了新的文献求助10
刚刚
1秒前
1秒前
1秒前
2秒前
哈哈完成签到 ,获得积分10
2秒前
3秒前
4秒前
4秒前
温柔难敌发布了新的文献求助10
6秒前
6秒前
黑大帅发布了新的文献求助10
6秒前
amber发布了新的文献求助10
6秒前
美文完成签到 ,获得积分10
6秒前
7秒前
linmo发布了新的文献求助10
7秒前
卡皮巴拉发布了新的文献求助10
7秒前
8秒前
8秒前
FashionBoy应助phero采纳,获得10
8秒前
9秒前
LY完成签到 ,获得积分10
9秒前
halosheep发布了新的文献求助10
10秒前
榕榕榕发布了新的文献求助10
11秒前
JamesPei应助Vicky采纳,获得10
11秒前
CodeCraft应助Della666采纳,获得10
12秒前
12秒前
干不二发布了新的文献求助30
12秒前
12秒前
迷路柜子完成签到,获得积分10
13秒前
14秒前
慕青应助荞面小肉包采纳,获得10
14秒前
卡皮巴拉完成签到,获得积分10
14秒前
陈晓迪1992完成签到,获得积分10
14秒前
orixero应助amber采纳,获得10
15秒前
科目三应助万刈采纳,获得10
16秒前
17秒前
高分求助中
Sustainability in Tides Chemistry 2000
The ACS Guide to Scholarly Communication 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3075929
求助须知:如何正确求助?哪些是违规求助? 2728863
关于积分的说明 7506362
捐赠科研通 2377068
什么是DOI,文献DOI怎么找? 1260391
科研通“疑难数据库(出版商)”最低求助积分说明 610974
版权声明 597164